secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0000950170-23-073865
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mark Chin resigns from Iterum board effective Dec 31, 2023
-------------------------------------------------------------------

- Mark Chin notified Company on Dec 28, 2023 of resignation from Board effective Dec 31.
- Resignation due to desire to reduce public board commitments because of new job.
- No disagreement with Company's operations, policies, or practices cited.
- Chin served on Board for over six and a half years; Company thanked him.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017023073865/0000950170-23-073865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017023073865/itrm-20231229.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-073865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer